
Bavarian Nordic A/S, the only maker of an approved vaccine to prevent monkeypox, is in talks to supply several countries that have identified cases of the viral infection.
The Danish company’s production could be ramped up to 30 million doses a year if necessary, Chief Financial Officer Henrik Juuel said in a phone interview.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app